Variant detail

KCNH2I82dup

c.244dup · residue 82 · I → dup
HGVS annotation

ClinVar-style identity and transcript context

ClinVar-style HGVS
NM_000238.4(KCNH2):c.244dup (I82dup)
HGVSc
c.244dup
cDNA change
c.244dup
RefSeq transcript
NM_000238.4
Ensembl transcript
ENST00000262186.10
Protein HGVS
I82dup
Genomic coordinate
Chr7 150671862
LQT2 penetrance Low risk
0% CI pending
0%20%50%100%

Limited evidence · n=1 1 observed LQT2 carriers · NA hypothetical affected and NA hypothetical unaffected

One-sentence summary

Roughly fewer than 1 in 100 people who carry I82dup are estimated to eventually be diagnosed with Long QT type 2 — low risk penetrance, based on 1 carriers reported so far.

Structure: Hotspot. Functional evidence: MAVE not available.

Executive summary

Sources used for interpretation

The LQT2 penetrance estimate combines observed carrier counts with a feature-based model starting point. Other rows summarize supporting annotations for interpretation; not every row is a direct input to the model.

Estimatemodel output Observedmeasured in people/assays Model inputassumed, not observed Predictedcomputational Externalthird-party

Evidence

Carriers observed
1
1 LQT2 · 0 unaffected · 0 gnomAD
Model prior: NA hypothetical affected · NA hypothetical unaffected
Limited evidence
Functional data
Not characterized
MAVE not available · 0 published functional studies
Predictors and density
REVELrange 0-1
LQT2 densityHotspot region0.696range 0-1
PolyPhen-2range 0-1
PROVEANcutoff <= -2.5
BLAST-PSSMlower = less tolerated
Overall0/5
Range labels show the expected scale or cutoff. Calls are rough orientation from published cutoffs (hover a row) — not a clinical classification.

Automated ACMG/AMP review prompts

Generated from available data — not a clinical classification
PS3not met
Functional studies or MAVE support effect
PM1review
Hotspot or high LQT2 density
PM2met · moderate
Absent or extremely rare in population data
PP3not met
Computational predictors support effect
BS1not met
Allele frequency too high for disorder

Reported carrier data

Paper / cohort Carriers LQT2 / affected Unaffected / ambiguous Other observations Variant context
Year 2012 · clinical carrier record
1 1 LQT2 0 unaffected / ambiguous Not separately annotated
Variant I82dup
Curated carrier-count row
gnomAD population observations (v4) 0 0 LQT2 0 Population observations; not known affected cases. gnomAD v4 allele count.
Combined literature, cohort, and gnomAD 1 1 LQT2 0 Combined totals used in the penetrance estimate. Curated carrier totals for this variant.
Hypothetical observations from model prior (not observed patients) NA NA hypothetical LQT2 affected NA hypothetical unaffected Feature-based pseudo-counts added before observed carriers. Model input; not literature or gnomAD evidence.

Model starting point. The penetrance model starts with NA hypothetical affected and NA hypothetical unaffected observations derived from variant features, then updates that starting point with the real carrier counts above. As observed carrier counts grow, this feature-based starting point has less influence.

Nearby variants · researcher detail
Neighbour residueDistance (A)Observed variants
820.0 I82Del, I82dup, I82Ins, I82T,
834.5 A83P, A83fsX,
795.1 A79T, A79S, A79Del, A79fsX,
815.4 Q81E, Q81X, Q81P, Q81H, Q81H,
805.5 A80P,
855.9 A85P, A85V,
946.5 V94L, V94L, V94A,
656.6 T65P,
786.9 A78T, A78P,
846.9
866.9 L86R,
1107.3 V110A,
1127.8 V112M,
928.0 R92C, R92L,
648.3 C64R, C64Y,
968.6 I96V, I96T,
669.2 C66R, C66G, C66Y,
779.3 R77S,
1279.4
8710.1 L87P,
7010.3 H70R, H70Q, H70Q,
7610.4
11110.6 D111V,
12510.7
9810.7
9510.9 E95K, E95G,
9010.9 E90K,
9311.2 K93X, K93R,
8811.2
6711.2
10911.3 L109X, L109Q, L109P,
7511.5 Q75X,
6311.7 P63H,
12911.7 F129C,
6911.8 L69Del, L69P,
7411.9 T74fsX, T74M,
10812.0 C108Y,
8912.0 A89G, A89V,
3912.0 C39R, C39X,
11312.2 V113Del,
9712.2
9112.3
11412.5 P114S,
3012.8 I30Del, I30T,
12612.9
12813.0 N128S,
3213.1 A32T
6813.8 F68L, F68V, F68L, F68L,
7114.2 G71R, G71R, G71W, G71E,
3814.2
4114.8 V41A,
4014.8
10714.9 L107P,
External resources